|
|
Article: Guidance On Acceptance Of Foreign Clinical Studies Released By FDA : Ethical principles clarified, public comments requested.
- Article from:
- Biomedical Market Newsletter
- Article date:
- March 31, 2001
CopyrightCOPYRIGHT 2001 Biomedical Market Newsletter, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
On March 13, 2001, the US FDA released final guidance to clarify the ethical principles with which a company must comply, before FDA will accept a foreign clinical study that was not conducted under an FDA-approved IND or IDE (investigational new drug application or investigational device exemption). No deadline was set for submittal of written comments.
Final approval of an FDA-sanctioned standard methodology for accepting foreign clinical trial results, will almost certainly result in cost savings of thousands of dollars for small manufacturers. For larger firms (especially drug manufacturers/developers), the savings would be many millions of dollars.
...